113 related articles for article (PubMed ID: 2870315)
1. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing.
Hinz J; Hautzinger H; Stahl KW
Lancet; 1986 Apr; 1(8485):825-8. PubMed ID: 2870315
[TBL] [Abstract][Full Text] [Related]
2. [Stimulation of wound healing by tetrachlordecaoxide. Results of a randomized double-blind study].
Hinz J; Hautzinger H; Helling J; Schirren G; Sell G; Stahl KW; Kühne FW
Fortschr Med; 1984 May; 102(18):523-8. PubMed ID: 6376301
[TBL] [Abstract][Full Text] [Related]
3. [Increase of oxygen partial pressure and acceleration of wound healing by tetrachlorodecaoxide].
Weiler-Mithoff EM; Friederich HC; Horn W; Issing K
Z Hautkr; 1989 Mar; 64(3):208-11. PubMed ID: 2718552
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of tetrachlorodecaoxide (TCDO) in the treatment of complicated disorders of wound healing. A controlled study: TCDO versus PVP-iodine complex].
Zenker W; Thiede A; Dommes M; Ullmann U
Chirurg; 1986 May; 57(5):334-9. PubMed ID: 3525029
[TBL] [Abstract][Full Text] [Related]
5. Failure of tetrachlorodecaoxygen anion complex to assist wound healing.
Hughes LE; Marks J; Harding KG
Lancet; 1989 Nov; 2(8674):1271. PubMed ID: 2573775
[No Abstract] [Full Text] [Related]
6. Anti-inflammatory properties of a novel wound healing and immunomodulating agent, tetrachlorodecaoxygen complex (TCDO).
Tissot M; Roch-Arveiller M; Mathieu J; Giroud JP; Stahl KW
Agents Actions; 1990 Nov; 31(3-4):368-74. PubMed ID: 1964762
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study].
Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S
Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Negative-Pressure Wound Therapy with Tetrachlorodecaoxygen-Anion Complex Instillation Compared with Standard Negative-Pressure Wound Therapy for Accelerated Wound Healing: A Prospective, Randomized, Controlled Trial.
Burusapat C; Sringkarawat S
Plast Reconstr Surg; 2021 Aug; 148(2):339-352. PubMed ID: 34153022
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with tetrachlorodecaoxide in the local treatment of difficult-to-heal wounds].
Weise K; Evers KH
Aktuelle Traumatol; 1988 Oct; 18(5):219-25. PubMed ID: 2907247
[TBL] [Abstract][Full Text] [Related]
10. Recent findings limiting immunological and photosensitizing hazards of the tetrachlorodecaoxygen anion complex (TCDO) in wound healing promotion.
Stahl KW; Kühne FW; Weiler EM
Br J Dermatol; 1986 Aug; 115 Suppl 31():142-7. PubMed ID: 3755612
[No Abstract] [Full Text] [Related]
11. The tetrachlorodecaoxygen complex reverses the effect of cortisone on wound healing.
Hatz RA; Kelley SF; Ehrlich HP
Plast Reconstr Surg; 1989 Dec; 84(6):953-9. PubMed ID: 2587659
[TBL] [Abstract][Full Text] [Related]
12. Local tetrachlorodecaoxide treatment to improve oxygen supply to non-healing wounds.
Hinz J; Kühne FW; Stahl KW
Lancet; 1984 Sep; 2(8403):630. PubMed ID: 6147652
[No Abstract] [Full Text] [Related]
13. Tetrachlorodecaoxygen anion complex treatment after localized X irradiation of the rat colon.
Breiter N; Sassy T; Trott KR
Br J Radiol; 1989 Apr; 62(736):381-3. PubMed ID: 2713600
[No Abstract] [Full Text] [Related]
14. [Healing of arterial and venous ulcers with TCDO. Insight into the mechanisms of tissue repair].
Stahl KW; Chastang C
Fortschr Med; 1988 Jan; 106(1):44-6. PubMed ID: 3350464
[No Abstract] [Full Text] [Related]
15. Use of topical ketanserin in the treatment of skin ulcers: a double-blind study.
Janssen PA; Janssen H; Cauwenbergh G; De Doncker P; De Beule K; Lewi P; Tytgat HF; Lapière CM
J Am Acad Dermatol; 1989 Jul; 21(1):85-90. PubMed ID: 2663937
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial effects of the tetrachlorodecaoxygen-anion complex on oropharyngeal bacterial flora: an in vitro study.
Stoll P; Huber H; Pelz K; Weingart D
Chemotherapy; 1993; 39(1):40-7. PubMed ID: 8444059
[TBL] [Abstract][Full Text] [Related]
17. Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial.
Yingsakmongkol N; Maraprygsavan P; Sukosit P
J Foot Ankle Surg; 2011; 50(6):635-40. PubMed ID: 21723750
[TBL] [Abstract][Full Text] [Related]
18. [Control of the re-epithelialization of skin defects and burns].
Stoll P; Weingart D; Nilles A; Kindermann D; Hültenschmidt D
Dtsch Z Mund Kiefer Gesichtschir; 1989; 13(4):260-5. PubMed ID: 2637073
[TBL] [Abstract][Full Text] [Related]
19. Ketanserin promotes wound healing: clinical and preclinical results.
Rooman RP; Janssen H
Prog Clin Biol Res; 1991; 365():115-28. PubMed ID: 1862126
[No Abstract] [Full Text] [Related]
20. Increased resistance towards two systemic experimental infections by tetrachlorodecaoxygen anion complex. Possible implications of cellular and humoral immunity.
Gillissen G; Kühne FW; Breuer-Werle M; Melzer B; Ostendorp H
Arzneimittelforschung; 1986 Dec; 36(12):1778-82. PubMed ID: 3566839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
